NRF2 is a critical regulator and therapeutic target of metal implant particle-incurred bone damage
Jian Dong(Fudan University), Wangsen Cao(Nanjing University of Chinese Medicine), Hongwei Wang(State Key Laboratory of Analytical Chemistry for Life Science), Lijun Zhang(Tongji University), Yongxiang Wang(Sichuan University), Binjia Ruan(Northern Jiangsu People's Hospital), Zhongyang Lv(Nanjing General Hospital of Nanjing Military Command), Qing Jiang(Nanchang University)
Cited by 32
Related Papers
METTL3-mediated m6A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression
|Annals of the Rheumatic Diseases|2021|360
Basic study of corn protein, zein, as a biomaterial in tissue engineering, surface morphology and biocompatibility
|Biomaterials|2003|273
TRPV1 alleviates osteoarthritis by inhibiting M1 macrophage polarization via Ca2+/CaMKII/Nrf2 signaling pathway
|Cell Death and Disease|2021|241
FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma
|Clinical Cancer Research|2020|186